Board of Directors Declares $0.06 Per Share Cash DividendAuthorizes $25 Million Share Repurchase Program2019 Full Year Financial HighlightsRecord 2019 revenue […]
NEW YORK, Feb. 25, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, […]